Goodwin's Private Equity team advised Altasciences in the completion of its acquisition of Sinclair Research, a preclinical CRO located in the Midwest.
Complementing existing locations on the East and West Coast, the new site will facilitate even greater access to Altasciences’ preclinical services across the U.S.
Altasciences is an integrated drug development solution company offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services.
The Goodwin team was led by Matthew Mauney, and Amina Mokel.
For additional details on the acquisition, please read the press release.
Find out more about Private Equity, Life Sciences and Mergers & Acquisitions today, and keep up-to-date with the latest developments in Private Equity News.